Emerging Roles of Complement Protein C1q in Neurodegeneration
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Previous studies have shown that weak synapses of damaged neurons are tagged with complement components C1q and C3, which sends “eat me” signals to microglia initiating pathological pruning of stressed but viable neurons that may have had the potential to survive (53–55).”
From A human pluripotent stem cell triculture platform to elucidate microglial regulation of retinal ganglion cells in neuroinflammation (2026) · cites this paper as [55]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Bialas, A. R., & Stevens, B. (2013) · Nature Neuroscience · doi:10.1038/nn.3560 · Cited by 519 · cited 3×
“Recently, astrocyte-derived TGF-β was found to induce C1q in purified RGCs [54].”
BackgroundInfluentialRetractedNeurotoxic reactive astrocytes are induced by activated microglia
Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., Bennett, M. L., Münch, A. E., Chung, W.-S., Peterson, T. C., et al. (2017) · Nature · doi:10.1038/nature21029 · Cited by 7,971
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
The Classical Complement Cascade Mediates CNS Synapse Elimination
Stevens, B., Allen, N. J., Vazquez, L. E., Howell, G. R., Christopherson, K. S., Nouri, N., Micheva, K. D., Mehalow, A. K., Huberman, A. D., Stafford, B., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.036 · Cited by 3,313
Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S. W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81369-0 · Cited by 3,073
Synaptic Activity and the Construction of Cortical Circuits
Katz, L. C., & Shatz, C. J. (1996) · Science · doi:10.1126/science.274.5290.1133 · Cited by 3,048 · cited 1×
“The retinogeniculate system is a classic experimental model for synaptic refinement [44, 47-49].”
MethodMelanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease
Hirsch, E., Graybiel, A. M., & Agid, Y. A. (1988) · Nature · doi:10.1038/334345a0 · Cited by 1,301 · cited 1×
“The major feature of PD is a progressive demise of dopaminergic neurons in the substantia nigra pars compacta (SNc) [86].”
BackgroundNormal aging induces A1-like astrocyte reactivity
Clarke, L. E., Liddelow, S. A., Chakraborty, C., Münch, A. E., Heiman, M., & Barres, B. A. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1800165115 · Cited by 1,237
In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease
Gerhard, A., Pavese, N., Hotton, G., Turkheimer, F., Es, M., Hammers, A., Eggert, K., Oertel, W., Banati, R. B., & Brooks, D. J. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.08.002 · Cited by 1,200 · cited 1×
“Several studies identified neuroinflammation in the brains of patients with PD using functional brain scanning and PK-11195, a microglial benzodiazepine receptor ligand [88, 89].”
BackgroundWu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D.-K., Ischiropoulos, H., & Przedborski, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01763.2002 · Cited by 1,183 · cited 1×
“microglia have been observed in animal models of PD, and it has been suggested that the modification of innate immune response plays a role in neuronal protection [90, 91].”
BackgroundLui, H., Zhang, J., Makinson, S. R., Cahill, M. K., Kelley, K. W., Huang, H.-Y., Shang, Y., Oldham, M. C., Martens, L. H., Gao, F., et al. (2016) · Cell · doi:10.1016/j.cell.2016.04.001 · Cited by 729 · cited 1×
“failure of this refinements in neuronal connectivity could lead to neurological disorders [43].”
BackgroundSelective vulnerability in neurodegenerative diseases
Fu, H., Hardy, J., & Duff, K. E. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0221-2 · Cited by 585 · cited 1×
“expressing D2-dopamine receptor, neurotensin, or metenkephalin are particularly vulnerable [95].”
BackgroundCerebral plasticity: windows of opportunity in the developing brain
Ismail, F. Y., Fatemi, A., & Johnston, M. V. (2017) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2016.07.007 · Cited by 572
A Dramatic Increase of C1q Protein in the CNS during Normal Aging
Stephan, A. H., Madison, D. V., Mateos, J. M., Fraser, D. A., Lovelett, E. A., Coutellier, L., Kim, L., Tsai, H.-H., Huang, E. J., Rowitch, D. H., et al. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.1333-13.2013 · Cited by 423 · cited 4×
“aged C1q-KO mice displayed cognitive decline, including memory function and some hippocampus-relevant behavior tests [36].”
BackgroundInfluentialEnhanced synaptic connectivity and epilepsy in C1q knockout mice
Chu, Y., Jin, X., Parada, I., Pesic, A., Stevens, B., Barres, B., & Prince, D. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913449107 · Cited by 364 · cited 2×
“In the developmental stage, the failure of synaptic pruning is an essential aspect of epileptogenesis [57].”
BackgroundCell-specific deletion of C1qa identifies microglia as the dominant source of C1q in mouse brain
Fonseca, M. I., Chu, S.-H., Hernandez, M. X., Fang, M. J., Modarresi, L., Selvan, P., MacGregor, G. R., & Tenner, A. J. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0814-9 · Cited by 337 · cited 2×
“With age, C1q protein expression increases up to 300fold, mainly secreted from microglia and some neurons [35].”
BackgroundDistinct roles for spontaneous and visual activity in remodeling of the retinogeniculate synapse
Hooks, B. M., & Chen, C. (2006) · Neuron · doi:10.1016/j.neuron.2006.07.007 · Cited by 311
Naviaux, J. C., Wang, L., Li, K., Bright, A., Alaynick, W. A., Williams, K. R., Powell, S. B., & Naviaux, R. K. (2015) · Molecular Autism · doi:10.1186/2040-2392-6-1 · Cited by 285
Complement System in Neural Synapse Elimination in Development and Disease
Presumey, J., Bialas, A. R., & Carroll, M. C. (2017) · Advances in Immunology · doi:10.1016/bs.ai.2017.06.004 · Cited by 276
The Amyloid Precursor Protein Is Developmentally Regulated and Correlated with Synaptogenesis
Moya, K. L., Benowitz, L. I., Schneider, G. E., & Allinquant, B. (1994) · Developmental Biology · doi:10.1006/dbio.1994.1055 · Cited by 157
Heikkinen, A., Pihlajaniemi, T., Faissner, A., & Yuzaki, M. (2014) · Progress in Brain Research · doi:10.1016/b978-0-444-63486-3.00002-5 · Cited by 42 · cited 1×
“innate immune system [3] by enhancing the phagocytosis of opsonized pathogens in which collagen-immobilized surfaces bind directly to the target molecules [19, 20].”
Background
Research works printed but not linked: 79
- Woodruff TM, Nandakumar KS, Tedesco F (2011). Inhibiting the C5-C5a receptor axis. Mol Immunol, 48:1631-1642. · DOI · Paper page
- Sim RB, Laich A (2000). Serine proteases of the complement system. Biochem Soc Trans, 28:545-550. · DOI
- Reid KBM (2018). Complement Component C1q: Historical Perspective of a Functionally Versatile, and Structurally Unusual, Serum Protein. Front Immunol, 9:764. · DOI
- Conti P, Shaik-Dasthagirisaheb YB (2015). Mast Cell Serotonin Immunoregulatory Effects Impacting on Neuronal Function: Implications for Neurodegenerative and Psychiatric Disorders. Neurotox Res, 28:147-153. · DOI
- Nayak A, Ferluga J, Tsolaki AG, Kishore U (2010). The non-classical functions of the classical complement pathway recognition subcomponent C1q. Immunol Lett, 131:139-150. · DOI
- Cho KJ, Cheon SY, Kim GW (2016). Apoptosis signal-regulating kinase 1 mediates striatal degeneration via the regulation of C1q. Sci Rep, 6:18840. · DOI
- Francis K, van Beek J, Canova C, Neal JW, Gasque P (2003). Innate immunity and brain inflammation: the key role of complement. Expert Rev Mol Med, 5:1-19. · DOI · Paper page
- Arlaud GJ, Gaboriaud C, Thielens NM, Rossi V (2002). Structural biology of C1. Biochem Soc Trans, 30:1001-1006. · DOI
- Rabs U, Martin H, Hitschold T, Golan MD, Heinz HP, Loos M (1986). Isolation and characterization of macrophage-derived C1q and its similarities to serum C1q. Eur J Immunol, 16:1183-1186. · DOI
- De Bracco MM, Manni JA (1974). Serum levels of C1q, C1r and C1s in normal and pathologic sera. Arthritis Rheum, 17:121-128. · doi:10.1002/art.1780170204
- Knobel HR, Villiger W, Isliker H (1975). Chemical analysis and electron microscopy studies of human C1q prepared by different methods. Eur J Immunol, 5:78-82. · doi:10.1002/eji.1830050119
- Brodsky-Doyle B, Leonard KR, Reid KB (1976). Circular-dichroism and electron-microscopy studies of human subcomponent C1q before and after limited proteolysis by pepsin. Biochem J, 159:279-286. · DOI · Paper page
- Kishore U, Ghai R, Greenhough TJ, Shrive AK, Bonifati DM, Gadjeva MG, et al. (2004). Structural and functional anatomy of the globular domain of complement protein C1q. Immunol Lett, 95:113-128. · DOI · Paper page
- Gaboriaud C, Teillet F, Gregory LA, Thielens NM, Arlaud GJ (2007). Assembly of C1 and the MBL- and ficolin-MASP complexes: structural insights. Immunobiology, 212:279-288. · doi:10.1016/j.imbio.2006.11.007
- Ghebrehiwet B, Hosszu KH, Peerschke EI (2017). C1q as an autocrine and paracrine regulator of cellular functions. Mol Immunol, 84:26-33. · DOI
- Kishore U, Gaboriaud C, Waters P, Shrive AK, Greenhough TJ, Reid KB, et al. (2004). C1q and tumor necrosis factor superfamily: modularity and versatility. Trends Immunol, 25:551-561. · DOI · Paper page
- Sim RB, Kishore U, Villiers CL, Marche PN, Mitchell DA (2007). C1q binding and complement activation by prions and amyloids. Immunobiology, 212:355-362. · DOI · Paper page
- Kakegawa W, Mitakidis N, Miura E, Abe M, Matsuda K, Takeo YH, et al. (2015). Anterograde C1ql1 signaling is required in order to determine and maintain a single-winner climbing fiber in the mouse cerebellum. Neuron, 85:316-329. · DOI · Paper page
- Lei X, Seldin MM, Little HC, Choy N, Klonisch T, Wong GW (2017). C1q/TNF-related protein 6 (CTRP6) links obesity to adipose tissue inflammation and insulin resistance. J Biol Chem, 292:14836-14850. · DOI · Paper page
- Beraudi A, Stea S, Bordini B, Baleani M, Viceconti M (2010). Osteon classification in human fibular shaft by circularly polarized light. Cells Tissues Organs, 191:260-268. · DOI
- Vegh Z, Kew RR, Gruber BL, Ghebrehiwet B (2006). Chemotaxis of human monocyte-derived dendritic cells to complement component C1q is mediated by the receptors gC1qR and cC1qR. Mol Immunol, 43:1402-1407. · DOI
- Leigh LE, Ghebrehiwet B, Perera TP, Bird IN, Strong P, Kishore U, et al. (1998). C1q-mediated chemotaxis by human neutrophils: involvement of gClqR and G-protein signalling mechanisms. Biochem J, 330 (Pt 1):247-254. · DOI
- Hooshmand MJ, Nguyen HX, Piltti KM, Benavente F, Hong S, Flanagan L, et al. (2017). Neutrophils Induce Astroglial Differentiation and Migration of Human Neural Stem Cells via C1q and C3a Synthesis. J Immunol, 199:1069-1085. · DOI
- Kantrow SP, Shen Z, Jagneaux T, Zhang P, Nelson S (2009). Neutrophil-mediated lung permeability and host defense proteins. Am J Physiol Lung Cell Mol Physiol, 297:L738-745. · DOI
- Perry VH, O’Connor V (2008). C1q: the perfect complement for a synaptic feast? Nat Rev Neurosci, 9:807-811. · DOI
- Goodman EB, Anderson DC, Tenner AJ (1995). C1q triggers neutrophil superoxide production by a unique CD18-dependent mechanism. J Leukoc Biol, 58:168-176. · DOI
- Lood C, Eriksson S, Gullstrand B, Jonsen A, Sturfelt G, Truedsson L, et al. (2012). Increased C1q, C4 and C3 deposition on platelets in patients with systemic lupus erythematosus--a possible link to venous thrombosis? Lupus, 21:1423-1432. · DOI · Paper page
- Madhukaran SP, Alhamlan FS, Kale K, Vatish M, Madan T, Kishore U (2016). Role of collectins and complement protein C1q in pregnancy and parturition. Immunobiology, 221:1273-1288. · DOI
- Xiao J, Li Y, Gressitt KL, He H, Kannan G, Schultz TL, et al. (2016). Cerebral complement C1q activation in chronic Toxoplasma infection. Brain Behav Immun, 58:52-56. · DOI
- Datwani A, McConnell MJ, Kanold PO, Micheva KD, Busse B, Shamloo M, et al. (2009). Classical MHCI molecules regulate retinogeniculate refinement and limit ocular dominance plasticity. Neuron, 64:463-470. · DOI · Paper page
- Cherubini E, Caiati MD, Sivakumaran S (2011). In the developing hippocampus kainate receptors control the release of GABA from mossy fiber terminals via a metabotropic type of action. Adv Exp Med Biol, 717:11-26. · DOI
- Williams PA, Tribble JR, Pepper KW, Cross SD, Morgan BP, Morgan JE, et al. (2016). Inhibition of the classical pathway of the complement cascade prevents early dendritic and synaptic degeneration in glaucoma. Mol Neurodegener, 11:26. · DOI · Paper page
- Stephan AH, Barres BA, Stevens B (2012). The complement system: an unexpected role in synaptic pruning during development and disease. Annu Rev Neurosci, 35:369-389. · DOI · Paper page
- Sekar A, Bialas AR, de Rivera H, Davis A, Hammond TR, Kamitaki N, et al. (2016). Schizophrenia risk from complex variation of complement component 4. Nature, 530:177-183. · DOI · Paper page
- Harry GJ (2013). Microglia during development and aging. Pharmacol Ther, 139:313-326. · DOI · Paper page
- Guido W (2008). Refinement of the retinogeniculate pathway. J Physiol, 586:4357-4362. · DOI · Paper page
- Hong YK, Chen C (2011). Wiring and rewiring of the retinogeniculate synapse. Curr Opin Neurobiol, 21:228-237. · DOI · Paper page
- Chen C, Regehr WG (2000). Developmental remodeling of the retinogeniculate synapse. Neuron, 28:955-966. · DOI · Paper page
- Jaubert-Miazza L, Green E, Lo FS, Bui K, Mills J, Guido W (2005). Structural and functional composition of the developing retinogeniculate pathway in the mouse. Vis Neurosci, 22:661-676. · DOI · Paper page
- Torborg CL, Feller MB (2004). Unbiased analysis of bulk axonal segregation patterns. J Neurosci Methods, 135:17-26. · DOI
- McLin VA, Hu CH, Shah R, Jamrich M (2008). Expression of complement components coincides with early patterning and organogenesis in Xenopus laevis. Int J Dev Biol, 52:1123-1133. · DOI
- Li X, Madison BB, Zacharias W, Kolterud A, States D, Gumucio DL (2007). Deconvoluting the intestine: molecular evidence for a major role of the mesenchyme in the modulation of signaling cross talk. Physiol Genomics, 29:290-301. · DOI
- Ma Y, Ramachandran A, Ford N, Parada I, Prince DA (2013). Remodeling of dendrites and spines in the C1q knockout model of genetic epilepsy. Epilepsia, 54:1232-1239. · DOI · Paper page
- Cortes JR, Sanchez-Diaz R, Bovolenta ER, Barreiro O, Lasarte S, Matesanz-Marin A, et al. (2014). Maintenance of immune tolerance by Foxp3+ regulatory T cells requires CD69 expression. J Autoimmun, 55:51-62. · DOI
- Kannan G, Crawford JA, Yang C, Gressitt KL, Ihenatu C, Krasnova IN, et al. (2016). Anti-NMDA receptor autoantibodies and associated neurobehavioral pathology in mice are dependent on age of first exposure to Toxoplasma gondii. Neurobiol Dis, 91:307-314. · DOI
- Beglopoulos V, Sun X, Saura CA, Lemere CA, Kim RD, Shen J (2004). Reduced beta-amyloid production and increased inflammatory responses in presenilin conditional knock-out mice. J Biol Chem, 279:46907-46914. · DOI · Paper page
- Mallucci GR (2009). Prion neurodegeneration: starts and stops at the synapse. Prion, 3:195-201. · DOI
- Selkoe DJ (2002). Alzheimer’s disease is a synaptic failure. Science, 298:789-791. · DOI · Paper page
- Kouser L, Madhukaran SP, Shastri A, Saraon A, Ferluga J, Al-Mozaini M, et al. (2015). Emerging and Novel Functions of Complement Protein C1q. Front Immunol, 6:317. · DOI · Paper page
- Farber K, Cheung G, Mitchell D, Wallis R, Weihe E, Schwaeble W, et al. (2009). C1q, the recognition subcomponent of the classical pathway of complement, drives microglial activation. J Neurosci Res, 87:644-652. · DOI · Paper page
- Lynch NJ, Willis CL, Nolan CC, Roscher S, Fowler MJ, Weihe E, et al. (2004). Microglial activation and increased synthesis of complement component C1q precedes blood-brain barrier dysfunction in rats. Mol Immunol, 40:709-716. · DOI
- Veerhuis R, Boshuizen RS, Morbin M, Mazzoleni G, Hoozemans JJ, Langedijk JP, et al. (2005). Activation of human microglia by fibrillar prion protein-related peptides is enhanced by amyloid-associated factors SAP and C1q. Neurobiol Dis, 19:273-282. · DOI
- Fraser DA, Pisalyaput K, Tenner AJ (2010). C1q enhances microglial clearance of apoptotic neurons and neuronal blebs and modulates subsequent inflammatory cytokine production. J Neurochem, 112:733-743. · DOI · Paper page
- Rambach G, Maier H, Vago G, Mohsenipour I, Lass-Florl C, Defant A, et al. (2008). Complement induction and complement evasion in patients with cerebral aspergillosis. Microbes Infect, 10:1567-1576. · doi:10.1016/j.micinf.2008.09.011
- Lue LF, Rydel R, Brigham EF, Yang LB, Hampel H, Murphy GM, Jr., et al. (2001). Inflammatory repertoire of Alzheimer’s disease and nondemented elderly microglia in vitro. Glia, 35:72-79. · DOI · Paper page
- Ingram G, Loveless S, Howell OW, Hakobyan S, Dancey B, Harris CL, et al. (2014). Complement activation in multiple sclerosis plaques: an immunohistochemical analysis. Acta Neuropathol Commun, 2:53. · DOI · Paper page
- Thomas A, Gasque P, Vaudry D, Gonzalez B, Fontaine M (2000). Expression of a complete and functional complement system by human neuronal cells in vitro. Int Immunol, 12:1015-1023. · DOI · Paper page
- Fan R, Tenner AJ (2004). Complement C1q expression induced by Abeta in rat hippocampal organotypic slice cultures. Exp Neurol, 185:241-253. · DOI · Paper page
- Pisalyaput K, Tenner AJ (2008). Complement component C1q inhibits beta-amyloid- and serum amyloid P-induced neurotoxicity via caspase- and calpain-independent mechanisms. J Neurochem, 104:696-707. · DOI · Paper page
- Benoit ME, Tenner AJ (2011). Complement protein C1q-mediated neuroprotection is correlated with regulation of neuronal gene and microRNA expression. J Neurosci, 31:3459-3469. · DOI
- Rupprecht TA, Angele B, Klein M, Heesemann J, Pfister HW, Botto M, et al. (2007). Complement C1q and C3 are critical for the innate immune response to Streptococcus pneumoniae in the central nervous system. J Immunol, 178:1861-1869. · DOI · Paper page
- Cai Q, Li Y, Pei G (2017). Polysaccharides from Ganoderma lucidum attenuate microglia-mediated neuroinflammation and modulate microglial phagocytosis and behavioural response. J Neuroinflammation, 14:63. · DOI
- Mahajan SD, Aalinkeel R, Parikh NU, Jacob A, Cwiklinski K, Sandhu P, et al. (2017). Immunomodulatory Role of Complement Proteins in the Neuropathology Associated with Opiate Abuse and HIV-1 Co-Morbidity. Immunol Invest, 46:816-832. · DOI
- Whitelaw BS (2018). Microglia-mediated synaptic elimination in neuronal development and disease. J Neurophysiol, 119:1-4. · DOI · Paper page
- Claasen AM, Guevremont D, Mason-Parker SE, Bourne K, Tate WP, Abraham WC, et al. (2009). Secreted amyloid precursor protein-alpha upregulates synaptic protein synthesis by a protein kinase G-dependent mechanism. Neurosci Lett, 460:92-96. · DOI
- Kishore U, Gupta SK, Perdikoulis MV, Kojouharova MS, Urban BC, Reid KB (2003). Modular organization of the carboxyl-terminal, globular head region of human C1q A, B, and C chains. J Immunol, 171:812-820. · DOI
- Nimmrich V, Grimm C, Draguhn A, Barghorn S, Lehmann A, Schoemaker H, et al. (2008). Amyloid beta oligomers (A beta (1-42) globulomer) suppress spontaneous synaptic activity by inhibition of P/Q-type calcium currents. J Neurosci, 28:788-797. · DOI · Paper page
- Depboylu C, Schafer MK, Arias-Carrion O, Oertel WH, Weihe E, Hoglinger GU (2011). Possible involvement of complement factor C1q in the clearance of extracellular neuromelanin from the substantia nigra in Parkinson disease. J Neuropathol Exp Neurol, 70:125-132. · DOI · Paper page
- Ouchi Y, Yoshikawa E, Sekine Y, Futatsubashi M, Kanno T, Ogusu T, et al. (2005). Microglial activation and dopamine terminal loss in early Parkinson’s disease. Ann Neurol, 57:168-175. · DOI · Paper page
- Breidert T, Callebert J, Heneka MT, Landreth G, Launay JM, Hirsch EC (2002). Protective action of the peroxisome proliferator-activated receptor-gamma agonist pioglitazone in a mouse model of Parkinson’s disease. J Neurochem, 82:615-624. · DOI · Paper page
- Zhang ET, Richards HK, Kida S, Weller RO (1992). Directional and compartmentalised drainage of interstitial fluid and cerebrospinal fluid from the rat brain. Acta Neuropathol, 83:233-239. · DOI · Paper page
- Hochmeister S, Zeitelhofer M, Bauer J, Nicolussi EM, Fischer MT, Heinke B, et al. (2008). After injection into the striatum, in vitro-differentiated microglia- and bone marrow-derived dendritic cells can leave the central nervous system via the blood stream. Am J Pathol, 173:1669-1681. · DOI
- Yamada T, McGeer PL, McGeer EG (1992). Lewy bodies in Parkinson’s disease are recognized by antibodies to complement proteins. Acta Neuropathol, 84:100-104. · DOI · Paper page
- Singhrao SK, Neal JW, Morgan BP, Gasque P (1999). Increased complement biosynthesis by microglia and complement activation on neurons in Huntington’s disease. Exp Neurol, 159:362-376. · DOI · Paper page
- Ona VO, Li M, Vonsattel JP, Andrews LJ, Khan SQ, Chung WM, et al. (1999). Inhibition of caspase-1 slows disease progression in a mouse model of Huntington’s disease. Nature, 399:263-267. · DOI · Paper page
- Bjorkqvist M, Wild EJ, Thiele J, Silvestroni A, Andre R, Lahiri N, et al. (2008). A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington’s disease. J Exp Med, 205:1869-1877. · DOI · Paper page
- Dalrymple A, Wild EJ, Joubert R, Sathasivam K, Bjorkqvist M, Petersen A, et al. (2007). Proteomic profiling of plasma in Huntington’s disease reveals neuroinflammatory activation and biomarker candidates. J Proteome Res, 6:2833-2840. · DOI · Paper page
- Wild E, Magnusson A, Lahiri N, Krus U, Orth M, Tabrizi SJ, et al. (2011). Abnormal peripheral chemokine profile in Huntington’s disease. PLoS Curr, 3:RRN1231. · DOI · Paper page
- Crocker SF, Costain WJ, Robertson HA (2006). DNA microarray analysis of striatal gene expression in symptomatic transgenic Huntington’s mice (R6/2) reveals neuroinflammation and insulin associations. Brain Res, 1088:176-186. · DOI
Cited by
Complement factor C1q mediates sleep spindle loss and epileptic spikes after mild brain injury
Holden, S. S., Grandi, F. C., Aboubakr, O., Higashikubo, B., Cho, F. S., Chang, A. H., Forero, A. O., Morningstar, A. R., Mathur, V., Kuhn, L. J., et al. (2021) · Science · doi:10.1126/science.abj2685 · Cited by 133
“Aberrant activation of C1, the initiating molecule of the classical complement cascade, can trigger elimination of synapses and contribute to the progression of neurodegenerative disease (24).”
BackgroundGamdzyk, M., Doycheva, D. M., Araujo, C., Ocak, U., Luo, Y., Tang, J., & Zhang, J. H. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01904-7 · Cited by 127
Microglia deficiency accelerates prion disease but does not enhance prion accumulation in the brain
Bradford, B. M., McGuire, L. I., Hume, D. A., Pridans, C., & Mabbott, N. A. (2022) · Glia · doi:10.1002/glia.24244 · Cited by 44
Harkin, J., Gomes, C., Afify, R., Patil, S. V., Hetzer, S. M., Tutrow, K. D., Peña, K. H., Baker, A., Lavekar, S. S., Huang, K.-C., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2522958123 · Cited by 3
Metadata
- Authors
- Cho, K.
- Venue
- Aging and disease
- Publisher
- Aging and Disease
- Published
- 2019
- Volume
- 10
- Issue
- 3
- Pages
- 652
- ISSN
- 2152-5250
- Cited by
- 72
- References
- 21
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.